Intramucosal bacteria in colon cancer and their elimination by probiotic strain Enterococcus faecium M-74 with organic selenium
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
16475505
DOI
10.1007/bf02931427
Knihovny.cz E-zdroje
- MeSH
- adenom mikrobiologie MeSH
- biopsie MeSH
- dospělí MeSH
- Enterobacteriaceae růst a vývoj izolace a purifikace MeSH
- Enterococcus faecium * růst a vývoj MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory tračníku mikrobiologie MeSH
- probiotika aplikace a dávkování farmakologie MeSH
- selen metabolismus MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- střevní sliznice mikrobiologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- selen MeSH
Intraepithelial bacteria were isolated by the gentamicin protection assay (GPA) from biopsy samples obtained at colonoscopy (colon cancer, n = 10 patients; colonic adenoma, n = 20; control group, n = 20; cancer patients without gastrointestinal tract GIT malignancy, n = 10). After a three-month administration of E. faecium M-74 to patients with positive GPA biopsies, 172 biopsy specimens from 60 patients were examined with the GPA. The number of biopsies with intracellular bacteria was significantly higher in adenoma and carcinoma group than in control group (26 vs. 10%; p = 0.004); in cancer patients without GIT malignancy the difference was nonsignificant. E. faecium M-74 was also administered to 5 patients with colonic adenoma; according to a control colonoscopy the number of biopsies with intracellular bacteria was significantly lower after probiotic administration (48 vs. 16%; p = 0.03). A striking prevalence of intraepithelial bacteria was also showed in patients with large bowel adenoma and carcinoma. The administration of probiotic strain M-74 can thus be considered to be an effective and promising method for elimination of pathogenic bacteria in the case of inflammatory bowel disease and colon cancer.
Zobrazit více v PubMed
World J Microbiol Biotechnol. 1995 May;11(3):294-8 PubMed
Folia Microbiol (Praha). 2004;49(3):301-5 PubMed
Bratisl Lek Listy. 1999 May;100(5):238-45 PubMed
Am J Clin Nutr. 2001 Feb;73(2 Suppl):451S-455S PubMed
Folia Microbiol (Praha). 2004;49(2):143-6 PubMed
Folia Microbiol (Praha). 2003;48(3):417-26 PubMed
Infect Immun. 2001 Sep;69(9):5529-37 PubMed
Aliment Pharmacol Ther. 2003 Jul 1;18(1):45-56 PubMed
Gastroenterology. 1998 Aug;115(2):281-6 PubMed
Gut. 2003 Jul;52(7):988-97 PubMed
Gastroenterology. 2004 Jul;127(1):80-93 PubMed
Folia Microbiol (Praha). 2002;47(5):573-8 PubMed
Gastroenterology. 2002 Jan;122(1):44-54 PubMed
J Antimicrob Chemother. 2001 May;47(5):709-10 PubMed
Gastroenterology. 2004 Aug;127(2):412-21 PubMed
Inflamm Bowel Dis. 2004 May;10(3):286-99 PubMed
Inhibitory potential of lactobacilli against Escherichia coli internalization by HT 29 cells
Probiotic potential of enterococci isolated from canine feed
Antimicrobial susceptibility of Enterococcus species isolated from Slovak Bryndza cheese
Probiotics manipulate host cytokine response and induce antimicrobial peptides
Effect of lactobacilli on E. coli adhesion to Caco-2 cells in vitro
Oral application of Enterococcus faecium strain EE3 in healthy dogs